Priorix
Generic name:measels, mumps, and rubella vaccine
Dosage form: kit
Drug class:Vaccine combinations
Medically reviewed by Drugs.com. Last updated on Jun 1, 2022.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Priorix
Priorix is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.
Priorix Dosage and Administration
For subcutaneous injection only.
Dose and Schedule
After reconstitution, a single dose of Priorix is approximately 0.5 mL.
Administer according to the following schedule:
- •
- First dose – 12 through 15 months of age
- •
- Second dose – 4 through 6 years of age
If Priorix is not administered according to this schedule and 2 doses of measles-, mumps- and rubella-virus vaccine are recommended for an individual, there should be a minimum of 4 weeks between the first and second dose.
Priorix may be administered as a second dose to individuals who have received a first dose of another measles, mumps and rubella virus-containing vaccine.
Preparation
Reconstitute the Lyophilized Antigen Component, Live only with the accompanying Sterile Water Diluent Component to form Priorix. The reconstituted vaccine should be a clear peach- to fuchsia pink-colored suspension. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, do not administer the vaccine.
